Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)

SHE:002198 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	403.38	376.17	533.03	659.03	574.28	543.85
Other Revenue	-	-	0.2	0.17	0.44	0.88
Revenue	403.38	376.17	533.23	659.2	574.71	544.73
Revenue Growth (YoY)	-19.19%	-29.45%	-19.11%	14.70%	5.50%	8.84%
Cost of Revenue	147.66	150.72	186.34	229.22	143.26	148.08
Gross Profit	255.73	225.44	346.9	429.98	431.45	396.65
Selling, General & Admin	201.16	185.89	292.82	351.17	379.1	346.89
Research & Development	6.43	6.76	10.1	15.34	14.4	9.38
Other Operating Expenses	6.45	5.97	9.07	10.59	10.67	9.51
Operating Expenses	214.03	198.62	311.34	379.76	402.16	366.85
Operating Income	41.7	26.83	35.56	50.22	29.29	29.8
Interest Expense	-	-	-0	-0.45	-1.02	-3.99
Interest & Investment Income	0.68	0.68	2.7	2.74	3.67	1.32
Earnings From Equity Investments	-	-	-	-	-	-3.64
Other Non Operating Income (Expenses)	-3.08	-2.82	0.01	-0	1.48	-0.03
EBT Excluding Unusual Items	39.29	24.68	38.27	52.5	33.42	23.46
Gain (Loss) on Sale of Investments	0.08	-	0.53	0.26	-28.8	-
Gain (Loss) on Sale of Assets	0	1.61	0.14	-0.01	-0.19	-0.03
Asset Writedown	-1.19	-1.19	-	-	-0.01	-0.02
Other Unusual Items	-	-	0.44	-1.65	1.39	-0.39
Pretax Income	38.18	25.1	39.37	51.1	5.82	23.02
Income Tax Expense	7.35	4.48	5.05	7.16	4.35	3.18
Net Income	30.83	20.61	34.32	43.93	1.48	19.84
Net Income to Common	30.83	20.61	34.32	43.93	1.48	19.84
Net Income Growth	12.87%	-39.94%	-21.88%	2874.04%	-92.55%	-
Shares Outstanding (Basic)	507	508	508	507	509	507
Shares Outstanding (Diluted)	507	508	508	507	509	507
Shares Change (YoY)	-0.09%	-0.00%	0.07%	-0.41%	0.40%	-0.01%
EPS (Basic)	0.06	0.04	0.07	0.09	0.00	0.04
EPS (Diluted)	0.06	0.04	0.07	0.09	0.00	0.04
EPS Growth	12.97%	-39.94%	-21.94%	2886.21%	-92.58%	-
Free Cash Flow	-1.15	22.14	93.39	24.41	49.46	85.19
Free Cash Flow Per Share	-0.00	0.04	0.18	0.05	0.10	0.17
Dividend Per Share	-	-	0.050	-	-	-
Gross Margin	63.40%	59.93%	65.05%	65.23%	75.07%	72.82%
Operating Margin	10.34%	7.13%	6.67%	7.62%	5.10%	5.47%
Profit Margin	7.64%	5.48%	6.44%	6.67%	0.26%	3.64%
Free Cash Flow Margin	-0.28%	5.89%	17.51%	3.70%	8.61%	15.64%
EBITDA	60.19	46.45	59.7	76.11	57.69	57.99
EBITDA Margin	14.92%	12.35%	11.20%	11.55%	10.04%	10.64%
D&A For EBITDA	18.49	19.62	24.14	25.89	28.4	28.19
EBIT	41.7	26.83	35.56	50.22	29.29	29.8
EBIT Margin	10.34%	7.13%	6.67%	7.62%	5.10%	5.47%
Effective Tax Rate	19.25%	17.87%	12.83%	14.02%	74.63%	13.83%
Revenue as Reported	-	-	533.23	659.2	574.71	544.73
Advertising Expenses	-	-	52.85	63.8	59.47	52.34

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.